Related Experiment Videos
[Giant-cell arteritis with initial resistance to corticosteroids (author's transl)]
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|January 7, 1982
Summary
Giant-cell arteritis (GCA) treatment typically uses corticosteroids. In rare cases, GCA resistant to cortisone was successfully treated by switching to a different corticosteroid medication.
Area of Science:
- Rheumatology
- Internal Medicine
- Pathology
Background:
- Giant-cell arteritis (GCA), also known as Horton arteritis, is a primary vasculitis of large and medium arteries.
- Corticosteroids are the cornerstone of GCA treatment, aiming to reduce inflammation and prevent complications.
Observation:
- This report details three uncommon cases of GCA exhibiting initial resistance to cortisone therapy.
- Diagnosis in these cases was confirmed through histopathological examination of biopsy specimens.
Findings:
- Resistance to initial corticosteroid treatment was overcome by substituting with an alternative corticosteroid.
- The switch in corticosteroid medication effectively managed the GCA symptoms and inflammation.
Implications:
- These cases highlight the importance of considering alternative corticosteroid strategies when initial treatment fails in GCA.
- Further research may explore specific mechanisms of corticosteroid resistance in GCA and identify optimal treatment pathways.